Area9 Lyceum and the American Association for Clinical Chemistry (AACC) have released an adaptive learning module on COVID-19, using AACC Learning Lab for Laboratory Medicine on NEJM Knowledge+.
The module addresses the origin of COVID-19, how it is transmitted, symptoms and differences in severity, complications, diagnosis, and prevention. The learning is now available at no cost to medical and laboratory professionals on the Area9 website.
"The adaptive learning module about COVID-19 is meant to inform and support the efforts of medical and laboratory professionals in their work to help contain and prevent the spread of the novel coronavirus," said Nader Rifai, Ph.D., Professor of Pathology at Harvard Medical School and Director of Clinical Chemistry at Boston Children's Hospital.
The World Health Organization (WHO), in commenting on the increasing number of confirmed COVID-19 worldwide, stated: "Every effort to contain the virus and slow the spread saves lives. These efforts give health systems and all of society much needed time to prepare, and researchers more time to identify effective treatments and develop vaccines."
The COVID-19 adaptive learning module is also in support of the United Nations Sustainable Development Goals—in particular, Goal No. 3 of the UN SDGs, which seeks to improve good health and wellbeing and calls for more efforts to eradicate a wide range of diseases and address emerging health issues.
"By leveraging our strengths and expertise in precision-learning methods that lead to learners building real capabilities, we are proud to be part of the effort to help stop the spread of COVID-19," said Ulrik Juul Christensen, M.D., Executive Chairman of Area9 Lyceum.
This innovation in education was developed in 2017 through a collaboration between NEJM Knowledge+, which is a product of NEJM Group—a division of the Massachusetts Medical Society—the organization behind the New England Journal of Medicine, and AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine.